Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%

CLINDAMYCIN PHOSPHATE

Standard Dose
EQ 12MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% is listed in Drugs@FDA under application 214401 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN PHOSPHATE Form and strength INJECTABLE;INJECTION - EQ 12MG BASE/ML Sponsor HIKMA Submission history Latest submission status date: 2023-04-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% is listed in Drugs@FDA under application 214401 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN PHOSPHATE Form and strength INJECTABLE;INJECTION - EQ 12MG BASE/ML Sponsor HIKMA Submission history Latest submission status date: 2023-04-05 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.